ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,352.96
      -0.02%
      US Tech 100
      18,545.20
      0.02%
      Dow Jones
      38,886.17
      0.20%
      Brent Oil
      79.965
      0.11%
      Bitcoin
      70,863.30
      0.14%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Corcept Therapeutics Inc (CORT)

      7. Corcept Therapeutics Inc (CORT) News

      CORT

      Corcept Therapeutics (CORT)

      Corcept Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:CORT
      DateTimeSourceHeadlineSymbolCompany
      06/06/20246:21PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
      06/05/20249:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
      06/05/20249:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
      06/05/20249:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
      06/05/20249:13PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
      06/05/20249:11PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
      06/05/20249:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
      06/03/20242:15PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CORTCorcept Therapeutics Inc
      06/03/20242:05PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CORTCorcept Therapeutics Inc
      06/03/20241:05PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CORTCorcept Therapeutics Inc
      06/03/20248:00AMGlobeNewswire Inc.Corcept Therapeutics Announces Presentations of Results of Pivotal Phase 3 GRACE Trial Evaluating Relacorilant in Patients with Hypercortisolism (Cushing’s Syndrome)NASDAQ:CORTCorcept Therapeutics Inc
      05/31/20244:47PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CORTCorcept Therapeutics Inc
      05/31/20244:46PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CORTCorcept Therapeutics Inc
      05/31/20244:45PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CORTCorcept Therapeutics Inc
      05/31/20244:44PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CORTCorcept Therapeutics Inc
      05/31/20244:43PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CORTCorcept Therapeutics Inc
      05/31/20244:41PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CORTCorcept Therapeutics Inc
      05/31/20244:40PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CORTCorcept Therapeutics Inc
      05/31/20244:39PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CORTCorcept Therapeutics Inc
      05/31/20244:38PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CORTCorcept Therapeutics Inc
      05/31/20244:38PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CORTCorcept Therapeutics Inc
      05/31/20244:38PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CORTCorcept Therapeutics Inc
      05/31/20244:01PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CORTCorcept Therapeutics Inc
      05/30/20249:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
      05/30/20248:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
      05/28/20247:53PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
      05/28/20241:22PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CORTCorcept Therapeutics Inc
      05/28/20241:14PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CORTCorcept Therapeutics Inc
      05/28/20248:00AMGlobeNewswire Inc.Corcept Announces Primary Endpoint Met in Pivotal Phase 3 GRACE Trial of Relacorilant in Patients With Hypercortisolism (Cushing’s Syndrome)NASDAQ:CORTCorcept Therapeutics Inc
      05/23/20244:11PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CORTCorcept Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:CORT

      Your Recent History

      BIT
      P1UQR9
      NLBNPIT1UQR9 20240621 650
      BIT
      P1V8C5
      NLBNPIT1V8C5 20240621 32...
      Delayed Upgrade Clock